Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Kumar Rashmi, Director. Director active across 1 company, notably Myriad Genetics INC. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €189k. Activity tracked since 3 June 2021. The latest transaction was disclosed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Rashmi Kumar is a Board Member at Myriad Genetics Inc. She is involved in overseeing the company's operations and formulating strategies aimed at enhancing performance. Her expertise in the healthcare sector is beneficial for the organization.